According to the audit report for the financial year 2018-19 and 2019-20, Drap was ineffective due to its non-composition. — APP/File
ISLAMABAD: While the Drug Regulatory Authority of Pakistan (Drap) is in the limelight for its important role in registering the Covid-19 vaccines and allowing its clinical trials across the country, the Auditor General of Pakistan (AGP) has found severe violations of rules in the authority and suggested appointment of a full-time head for it.
Besides, terming all decisions of Drap unlawful, the AGP has suggested that these be validated by the federal cabinet.
According to the audit report for the financial year 2018-19 and 2019-20, Drap was ineffective due to its non-composition as out of the total 13 directors, only one (director costing and pricing) held the position on a regular basis. The others held the posts on a temporary basis.